Biocatalytic preparation of optically active 4-(N,N-dimethylamino)pyridines for application in chemical asymmetric catalysis
摘要:
4-Chloro-2-(1-hydroxybenzyl)pyridine and 4-chloro-2-(1-hydroxyalkyl)pyridines were obtained with moderate to excellent enantiomeric excesses and high isolated yields by bioreduction with Baker's yeast of the corresponding ketones. The resulting optically active alcohols were transformed into adequate DMAP derivatives, which have been applied in asymmetric catalytic processes as nucleophilic catalysts in the stereoselective chemical alkoxycarbonylation of 1-phenylethanol or as chiral ligands in the enantioselective addition of diethylzinc to benzaldehyde. (c) 2006 Elsevier Ltd. All rights reserved.
Biocatalytic preparation of optically active 4-(N,N-dimethylamino)pyridines for application in chemical asymmetric catalysis
摘要:
4-Chloro-2-(1-hydroxybenzyl)pyridine and 4-chloro-2-(1-hydroxyalkyl)pyridines were obtained with moderate to excellent enantiomeric excesses and high isolated yields by bioreduction with Baker's yeast of the corresponding ketones. The resulting optically active alcohols were transformed into adequate DMAP derivatives, which have been applied in asymmetric catalytic processes as nucleophilic catalysts in the stereoselective chemical alkoxycarbonylation of 1-phenylethanol or as chiral ligands in the enantioselective addition of diethylzinc to benzaldehyde. (c) 2006 Elsevier Ltd. All rights reserved.
The present invention relates to light emitting materials including a novel Ir complex, where the Ir is provided with a primary ligand selected from phenyl pyridine ligands substituted with at least one Cl atom. Such light emitting materials have been found to have a significantly enhanced photoluminescence quantum yield over other Ir complexes with a phenyl pyridine ligand having no Cl atom, or even over those with a phenyl pyridine ligand having a halogen atom other than Cl, such as a Br or F atom, and as a result specifically improve the efficiency of a light emitting device. The present invention further relates to the use of such light emitting materials and an organic light emitting device including such light emitting materials.
Benzothiazolyl and Benzoxazolyl Hydrazones Function as Zinc Metallochaperones to Reactivate Mutant p53
作者:John A. Gilleran、Xin Yu、Alan J. Blayney、Anthony F. Bencivenga、Bing Na、David J. Augeri、Adam R. Blanden、S. David Kimball、Stewart N. Loh、Jacques Y. Roberge、Darren R. Carpizo
DOI:10.1021/acs.jmedchem.0c01360
日期:2021.2.25
[EN] (THIO)SEMICARBAZONE DERIVATIVES AND THEIR USE FOR TREATING CANCER<br/>[FR] DÉRIVÉS DE (THIO)SÉMICARBAZONE ET LEUR UTILISATION POUR LE TRAITEMENT DU CANCER
申请人:UNIV RUTGERS
公开号:WO2016123242A1
公开(公告)日:2016-08-04
The invention provides compounds of formula I and II and salts thereof, wherein R1, R2, Y, R3, and R4 have any of the meanings described in the specification, as well as compositions comprising such compounds and salts, and methods for treating cancer using such compounds and salts.
[EN] ZINC COMPLEXES OF HYDRAZONES AND (THIO)SEMICARBAZONES AND THEIR USE FOR THE TREATMENT OF CANCER<br/>[FR] COMPLEXES ZINC D'HYDRAZONES ET DE (THIO)SEMICARBAZONES ET LEUR UTILISATION POUR LE TRAITEMENT DU CANCER
申请人:UNIV RUTGERS
公开号:WO2016123250A1
公开(公告)日:2016-08-04
The invention provides complexes of Zn2+ of formulae (la) and (IIa) that are useful for treating cancer, as well as compositions and kits comprising such complexes.
Biocatalytic preparation of optically active 4-(N,N-dimethylamino)pyridines for application in chemical asymmetric catalysis
4-Chloro-2-(1-hydroxybenzyl)pyridine and 4-chloro-2-(1-hydroxyalkyl)pyridines were obtained with moderate to excellent enantiomeric excesses and high isolated yields by bioreduction with Baker's yeast of the corresponding ketones. The resulting optically active alcohols were transformed into adequate DMAP derivatives, which have been applied in asymmetric catalytic processes as nucleophilic catalysts in the stereoselective chemical alkoxycarbonylation of 1-phenylethanol or as chiral ligands in the enantioselective addition of diethylzinc to benzaldehyde. (c) 2006 Elsevier Ltd. All rights reserved.